GlassScriptPhysician profile
Joshua Taylor
NPI 1114164787
$102,137.11
in general payments reported to CMS, 2019-2025
28 companies · $3,238 in 2025
The $3,238 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,717 · 2020: $11K · 2021: $27K · 2022: $29K · 2023: $14K · 2024: $11K · 2025: $3,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $1,718 · Long Term Medical Supply Or Device Loan: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $23,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $1,717.99 |
| Long Term Medical Supply Or Device Loan | $788.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $99,520.89 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Integra Lifesciences Corporation | $833.00 | 2021-2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Stryker Corporation | $334.69 | 2022-2025 | Aequalis Ascend Flex, 1788, Actishield Cf |
| Medtronic, INC. | $331.07 | 2021-2023 | Aquamantys(Tm), Corevalve Evolut R |
| Endogastric Solutions, INC | $191.13 | 2021-2024 | Esophyx |
| Baxter Healthcare | $125.29 | 2019 | |
| Tela Bio, INC. | $102.13 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Evoke Pharma, INC. | $88.40 | 2024 | |
| W. L. Gore & Associates, INC. | $79.67 | 2023-2025 | Gore Enform Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Acell, INC. | $55.97 | 2019-2020 | |
| Kerecis Limited | $52.61 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $41.77 | 2020-2024 | Echelon Circular, Harmonic |
| Covidien LP | $39.86 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $34.64 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $33.78 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $30.13 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $26.97 | 2021-2023 | Regranex, Collagenase Santyl |
| Davol INC. | $25.08 | 2020-2021 | |
| Abbott Laboratories | $24.26 | 2021 | |
| Innovation Technologies INC | $23.57 | 2025 | Irrisept |
| Ambu INC. | $22.71 | 2024 | |
| Lucid Diagnostics INC. | $22.32 | 2023 | |
| Enterra Medical, INC. | $21.16 | 2025 | |
| Solventum Corporation | $19.20 | 2025 | Activ.A.C., Prevena |
| Innocoll Pharmaceuticals Limited | $18.26 | 2022 | |
| Cook Medical LLC | $14.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.78 | 2023 | Seglentis |
| Zyla Life Sciences, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.